
Deepmala Katiyar
About Deepmala Katiyar
Data last updated:
Deepmala Katiyar is a Director at Vitaegen Biotech Private Limited (since 2023) and Director at Prangenix Therapeutics Private Limited (since 2025). The companies operate in Education & Learing. The largest current company by reported revenue is Vitaegen Biotech Private Limited at ₹4 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Jun 2023 | 2009 | ₹4 Lakh (FY 2025) | Active | |
| Director | 21 Jun 2025 | 2025 | Active |
Board colleagues of Deepmala Katiyar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bharati Singh | 02612336 | Vitaegen Biotech Private Limited , Prangenix Therapeutics Private Limited | Director |
| Panch Deo Singh | 02612340 | Vitaegen Biotech Private Limited | Director |
| Shiv Prasad Katiyar | 07322531 | Vitaegen Biotech Private Limited | Director |
| Rajeev Vikram | 11166014 | Prangenix Therapeutics Private Limited | Director |
| Sushil Kumar Aggarwal | 11166015 | Prangenix Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepmala Katiyar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepmala Katiyar
Deepmala Katiyar currently holds 2 directorships: Vitaegen Biotech Private Limited (Director, since 20 Jun 2023, revenue ₹4 Lakh (FY 2025)); Prangenix Therapeutics Private Limited (Director, since 21 Jun 2025).
Deepmala Katiyar was first appointed on 20 Jun 2023 as Director at Vitaegen Biotech Private Limited. The most recent appointment on record is 21 Jun 2025 at Prangenix Therapeutics Private Limited.
The current boards of Deepmala Katiyar's companies include Bharati Singh (Vitaegen Biotech Private Limited), Panch Deo Singh (Vitaegen Biotech Private Limited), Shiv Prasad Katiyar (Vitaegen Biotech Private Limited), Rajeev Vikram (Prangenix Therapeutics Private Limited), Sushil Kumar Aggarwal (Prangenix Therapeutics Private Limited).